
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Cardiovasc. Med. , 10 May 2022
Sec. Cardio-Oncology
Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.920605
This article is part of the Research Topic Re-Balancing the Balance: Another story of cardio-oncology View all 21 articles
This article is a correction to:
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
A Corrigendum on
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
by Canale, M. L., Turazza, F., Lestuzzi, C., Parrini, I., Camerini, A., Russo, G., Colivicchi, F., Gabrielli, D., Gulizia, M. M., Oliva, S., Tarantini, L., Maurea, N., Rigacci, L., Petrolati, S., Casolo, G., and Bisceglia, I. (2021). Front. Cardiovasc. Med. 8:677544. doi: 10.3389/fcvm.2021.677544
In the original article, there were errors in “affiliations 10 and 11. Instead of “Division of Cardiology, Istituto Tumori Giovanni Paolo II, Bari, Italy,” it should be “UOSD Cardiologia di Interesse Oncologico - IRCCS Istituto Tumori “GIOVANNI Paolo II” Bari, Bari, Italy.”
Instead of “Divisione di Cardiologia, Arcispedale S. Maria Nuova, Reggio-Emilia, Italy,” it should be “Division of Cardiology, Arcispedale S. Maria Nuova, Azienda USL – IRCCS di Reggio-Emilia, Reggio-Emilia, Italy.”
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cardio-oncology, anthracyclines, trastuzumab, global longitudinal strain, cardiac biomarker, healthcare
Citation: Canale ML, Turazza F, Lestuzzi C, Parrini I, Camerini A, Russo G, Colivicchi F, Gabrielli D, Gulizia MM, Oliva S, Tarantini L, Maurea N, Rigacci L, Petrolati S, Casolo G and Bisceglia I (2022) Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey. Front. Cardiovasc. Med. 9:920605. doi: 10.3389/fcvm.2022.920605
Received: 14 April 2022; Accepted: 19 April 2022;
Published: 10 May 2022.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2022 Canale, Turazza, Lestuzzi, Parrini, Camerini, Russo, Colivicchi, Gabrielli, Gulizia, Oliva, Tarantini, Maurea, Rigacci, Petrolati, Casolo and Bisceglia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Maria Laura Canale, bWFyaWFsYXVyYS5jYW5hbGVAdXNsbm9yZG92ZXN0LnRvc2NhbmEuaXQ=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.